State Street’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-30,507
Closed -$3.39K – 4876
2022
Q4
$3.39K Hold
30,507
– – ﹤0.01% 4844
2022
Q3
$32K Hold
30,507
– – ﹤0.01% 4754
2022
Q2
$57K Sell
30,507
-4,383
-13% -$10.7K ﹤0.01% 4700
2022
Q1
$125K Sell
34,890
-14,610
-30% -$71.8K ﹤0.01% 4572
2021
Q4
$426K Hold
49,500
– – ﹤0.01% 4077
2021
Q3
$376K Buy
49,500
+9,800
+25% +$82.6K ﹤0.01% 4089
2021
Q2
$264K Sell
39,700
-41,491
-51% -$262K ﹤0.01% 4111
2021
Q1
$982K Buy
+81,191
New +$1.61M ﹤0.01% 3630

Other funds holding LHDX

State Street's LHDX Position: Q1 2023 in Review

State Street sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 30,507 shares — an estimated $3.39K sold.

State Street first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $982K in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • State Street reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • State Street sold 30,507 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $3.39K.
  • State Street first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • State Street's Lucira Health, Inc. Common Stock position peaked at $982K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.